Fibrocytes in chronic lung disease – Facts and controversies
Introduction
Fibrocytes are circulating mesenchymal cell precursors, derived from bone marrow and first identified by Bucala et al. [1] in 1994, studying the biology of wound repair and determining which factors were contributing to the development and accumulation of fibroblasts. Since this initial discovery, additional studies have contributed to the characterization of fibrocytes, with respect to their morphology, growth characteristics in vitro, their biological roles in vivo, and their potential utility as a biomarker and/or treatment target in human disease.
Despite extensive efforts, the role and functions of this cell in tissue repair and pathobiology of chronic tissue remodelling are still unclear. In the current literature, there are discrepancies concerning the ability to culture fibrocytes, their detection in the peripheral blood and their mechanistic role in disease, most likely related to different methodologies and variable disease stages and animal models that are used to investigate the fibrocyte. In the last few years there have been a number of excellent reviews on the subject of fibrocytes highlighting the current knowledge about these cells. This review will focus on what has been consistently shown about fibrocytes in humans and some of the areas that still require further attention and scientific work.
Section snippets
Multiple markers are used to identify fibrocytes
Fibrocytes are circulating bone marrow-derived mesenchymal progenitor cells [2], [3], [4], [5] co-expressing haematopoietic stem cell markers, monocyte lineage markers and fibroblast products [6], [7]. Fibrocytes, like some dendritic cell subsets, are most likely derived from precursors of the monocyte lineage, supported by the observation that they express the major histocompatibility complex class I and class II and the co-stimulatory molecules CD80 and CD86 [1], [6], [8]. Current evidence
Fibrocytes demonstrate phenotype plasticity
At present there is no single specific marker for fibrocytes (see Fig. 1). This may be due to the apparent plasticity and constant change of these cells and may explain some of the difficulties in tracking them. It is, however, believed that human fibrocytes in circulation probably represent an obligate intermediate stage of differentiation of one of the precursors of the monocyte lineage into mature fibroblasts and myofibroblasts at the tissue sites [14]. While many studies support the notion
Fibrocyte isolation and culture
Whilst identification and quantification of fibrocytes in peripheral blood is relatively straight forward, depending on the marker panel that is used, the isolation and culturing of these cells remains difficult. There are several protocols published, and most groups seem to follow the original method developed by Bucala et al. [8], [27] using RPMI- or DMEM-based culture media, supplemented with 10–20% foetal bovine serum. Modifications to this protocol have been proposed by Pilling et al. [28]
Potential roles of fibrocytes in tissue repair
The putative roles for fibrocytes in tissue injury and repair vary between the organ systems and experimental models studied. They are found in different models of tissue repair and experimental fibrosis including wounded skin, asthma, pulmonary vascular remodelling, and lung and liver fibrosis [2], [16], [28], [29], [30], [31]. Fibrocytes can be detected in human fibrotic disorders including idiopathic pulmonary fibrosis (IPF), chronic asthma, nephrogenic fibrosing dermopathy, scleroderma and
Fibrocytes are present in a variety of chronic lung diseases
There is evidence suggesting that fibrocytes contribute to lung remodelling at some stage [48], [49]. The presence of fibrocytes has been reported in the circulation and tissue of a variety of lung disorders in humans, e.g. in IPF, chronic asthma, and scleroderma (see Table 1). While there is no publication of a “normal” number of fibrocytes in tissue, there is some understanding of the numbers that can be expected in the circulation. Using the marker combination CD45+/Col-1 positivity, Bucala
Summary and outlook
The study of fibrocytes is an exciting new topic in the area of injury, repair and fibrosis in many organs and tissues. The cells themselves seem to be as dynamic as the entire field of research. Sometimes the promise of a new discovery runs ahead of the actual facts and knowledge, which may be the case for fibrocytes. Some of the current “facts” are: (1) Fibrocytes are versatile and multipotent mesenchymal cell precursors found in the peripheral blood. (2) Cells that look like fibrocytes can
References (58)
- et al.
Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow
Exp Cell Res
(2005) - et al.
Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes
Exp Hematol
(2006) - et al.
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis
J Hepatol
(2006) - et al.
Migratory fate and differentiation of blood monocyte subsets
Immunobiology
(2006) - et al.
The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses
Lab Invest
(2007) - et al.
CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury
Am J Pathol
(2005) - et al.
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis
Int J Biochem Cell Biol
(2008) - et al.
Improved serum-free culture conditions for the differentiation of human and murine fibrocytes
J Immunol Methods
(2009) - et al.
Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage
Am J Pathol
(2006) - et al.
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease
Biochem Biophys Res Commun
(2007)